199 related articles for article (PubMed ID: 12631334)
21. Serum stem cell factor level in renal transplant recipients with posttransplant erythrocytosis.
Kiykim AA; Genctoy G; Horoz M; Tiftik NE; Gok E; Altun B; Arici M; Haznedaroglu I
Artif Organs; 2009 Dec; 33(12):1086-90. PubMed ID: 19958348
[TBL] [Abstract][Full Text] [Related]
22. Erythrocytosis after renal transplantation: risk factors and relationship with GFR.
Nankivell BJ; Allen RD; O'Connell PJ; Chapman JR
Clin Transplant; 1995 Oct; 9(5):375-82. PubMed ID: 8541630
[TBL] [Abstract][Full Text] [Related]
23. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
24. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
[TBL] [Abstract][Full Text] [Related]
25. Losartan, an angiotensin-II receptor antagonist, reduces hematocrits in kidney transplant recipients with posttransplant erythrocytosis.
Klaassen RJ; van Gelder T; Rischen-Vos J; Deinum J; Man in't Veld AJ; Weimar W
Transplantation; 1997 Sep; 64(5):780-2. PubMed ID: 9311722
[TBL] [Abstract][Full Text] [Related]
26. Association of post-renal transplant erythrocytosis and microalbuminuria: response to angiotensin-converting enzyme inhibition.
Mulhern JG; Lipkowitz GS; Braden GL; Madden RL; O'Shea MH; Harvilchuck H; Guarnera JM; Germain MJ
Am J Nephrol; 1995; 15(4):318-22. PubMed ID: 7573190
[TBL] [Abstract][Full Text] [Related]
27. Association between gene polymorphisms of the components of the renin-angiotensin-aldosteron system, graft function, and the prevalence of hypertension, anemia, and erythrocytosis after kidney transplantation.
Kujawa-Szewieczek A; Kolonko A; Kocierz M; Szotowska M; Trusolt W; Karkoszka H; Gumprecht J; Chudek J; Więcek A
Transplant Proc; 2011 Oct; 43(8):2957-63. PubMed ID: 21996200
[TBL] [Abstract][Full Text] [Related]
28. Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia.
Thevenod F; Radtke HW; Grützmacher P; Vincent E; Koch KM; Schoeppe W; Fassbinder W
Kidney Int; 1983 Aug; 24(2):227-32. PubMed ID: 6355616
[TBL] [Abstract][Full Text] [Related]
29. Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?
Gleiter CH
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):489-92. PubMed ID: 8937931
[TBL] [Abstract][Full Text] [Related]
30. Factors inducing posttransplant erythrocytosis.
Lezaić V; Djukanović LJ; Pavlović-Kentera V; Clemons G; Biljanović-Paunović L
Eur J Med Res; 1997 Sep; 2(9):407-12. PubMed ID: 9300939
[TBL] [Abstract][Full Text] [Related]
31. Postrenal transplant erythrocytosis: further evidence implicating erythropoietin production by the native kidneys.
Martino R; Oliver A; Ballarín JM; Remacha AF
Ann Hematol; 1994 Apr; 68(4):201-3. PubMed ID: 8003562
[TBL] [Abstract][Full Text] [Related]
32. Ramipril in post-renal transplant erythrocytosis.
Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
[TBL] [Abstract][Full Text] [Related]
33. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines.
Morrone LF; Di Paolo S; Logoluso F; Schena A; Stallone G; Giorgino F; Schena FP
Transplantation; 1997 Sep; 64(6):913-8. PubMed ID: 9326420
[TBL] [Abstract][Full Text] [Related]
34. Effects of losartan on the treatment of posttransplant erythrocytosis.
Navarro JF; García J; Macía M; Mora C; Chahin J; Gallego E; Méndez ML; del Castillo N
Clin Nephrol; 1998 Jun; 49(6):370-2. PubMed ID: 9696433
[TBL] [Abstract][Full Text] [Related]
35. [Polycythemia after kidney transplantation].
Hestin D; Legrand E; Mertes M; Renoult E; Kessler M
Presse Med; 1992 Dec; 21(41):1973-4. PubMed ID: 1294956
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
Minerva Urol Nefrol; 2002 Sep; 54(3):189-92. PubMed ID: 12384621
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.
Glicklich D; Burris L; Urban A; Tellis V; Greenstein S; Schechner R; Devarajan P; Croizat H
J Am Soc Nephrol; 2001 Sep; 12(9):1958-1964. PubMed ID: 11518790
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II receptor type 1 expression in erythroid progenitors: Implications for the pathogenesis of postrenal transplant erythrocytosis.
Mrug M; Julian BA; Prchal JT
Semin Nephrol; 2004 Mar; 24(2):120-30. PubMed ID: 15017524
[TBL] [Abstract][Full Text] [Related]
39. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study.
Charfeddine K; Zaghdane S; Yaich S; Hakim A; Hachicha J
Saudi J Kidney Dis Transpl; 2008 May; 19(3):371-7. PubMed ID: 18445895
[TBL] [Abstract][Full Text] [Related]
40. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
